Overview

Study of Utilization Patterns of Dimethyl Fumarate in Germany

Status:
Completed
Trial end date:
2017-03-02
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to estimate the proportion of DMF use that is prescribed "on-label" versus "off-label". The secondary objectives are: To describe the demographic characteristics and medical history of DMF users; To describe prescription drug history and concomitant medication use of DMF users; To describe the duration of therapy in participants newly initiating DMF treatment; To describe the medical specialties of DMF prescribers.
Details
Lead Sponsor:
Biogen
Treatments:
Dimethyl Fumarate